Page last updated: 2024-09-05

erlotinib hydrochloride and Infections, Coronavirus

erlotinib hydrochloride has been researched along with Infections, Coronavirus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aldape, K; Cheng, K; Ruppin, E; Schäffer, AA; Schiff, E; Sinha, S	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Infections, Coronavirus

Article	Year
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression. Molecular systems biology, 2020, Volume: 16, Issue:7 Topics: A549 Cells; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Design; Drug Evaluation, Preclinical; Erlotinib Hydrochloride; Fluphenazine; HEK293 Cells; Humans; Kidney; Lung; MCF-7 Cells; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Systems Biology; Up-Regulation; Vemurafenib	2020

Article

Year

In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.

Molecular systems biology, 2020, Volume: 16, Issue:7

Topics: A549 Cells; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Design; Drug Evaluation, Preclinical; Erlotinib Hydrochloride; Fluphenazine; HEK293 Cells; Humans; Kidney; Lung; MCF-7 Cells; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Systems Biology; Up-Regulation; Vemurafenib

2020